跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Salresp-I - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Salresp-I
Approved
STANDARD
Salresp-I
Ahlcon Parenterals (India) Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
af0dfe92a26c23ab
Company
Ahlcon Parenterals (India) Ltd.
Type
Standard
Approval Details
Approval Id
af0dfe92a26c23ab
Drug Approval Philippines Name
Salresp-I
Product Name
Salresp-I
Registration Number
DRP-1419
Brand Name
Salresp-I
Generic Name
Salbutamol Sulfate + Ipratropium Bromide
Dosage Form
Solution For Inhalation
Dosage Strength
2.5 mg/500 mcg per 2.5 mL
Manufacturer
Ahlcon Parenterals (India) Ltd.
Importer
I.E. Medica Inc.
Distributor
I.E. Medica Inc.
Issuance Date
28 December 2021
Expiry Date
19 May 2027
Pharmacologic Category
Adrenergic in combination with anticholinergic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
af0dfe92a26c23ab
Type
Standard
Back to Philippines FDA Approvals